{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T04:43:17Z","timestamp":1781412197082,"version":"3.54.1"},"reference-count":157,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"project PN-III-P2-2.1-PED-2016-1826","award":["248PED\/2017"],"award-info":[{"award-number":["248PED\/2017"]}]},{"name":"Executive Unit for Financing Higher Education, Research, Development and Innovation (UEFISCDI)","award":["248PED\/2017"],"award-info":[{"award-number":["248PED\/2017"]}]},{"name":"INSERM","award":["248PED\/2017"],"award-info":[{"award-number":["248PED\/2017"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, is the leading cause of cancer-related mortality. It arises and progresses against fibrotic or cirrhotic backgrounds mainly due to infection with hepatitis viruses B (HBV) or C (HCV) or non-viral causes that lead to chronic inflammation and genomic changes. A better understanding of molecular and immune mechanisms in HCC subtypes is needed. Materials and Methods: To identify transcriptional changes in primary HCC tumors with or without hepatitis viral etiology, we analyzed the transcriptomes of 24 patients by next-generation sequencing. Results: We identified common and unique differentially expressed genes for each etiological tumor group and analyzed the expression of SLC, ATP binding cassette, cytochrome 450, cancer testis, and heat shock protein genes. Metascape functional enrichment analysis showed mainly upregulated cell-cycle pathways in HBV and HCV and upregulated cell response to stress in non-viral infection. GeneWalk analysis identified regulator, hub, and moonlighting genes and highlighted CCNB1, ACTN2, BRCA1, IGF1,\u00a0CDK1, AURKA, AURKB, and TOP2A in the HCV group and HSF1, HSPA1A, HSP90AA1, HSPB1, HSPA5, PTK2, and AURKB in the group without viral infection as hub genes. Immune infiltrate analysis showed that T cell, cytotoxic, and natural killer cell markers were significantly more highly expressed in HCV than in non-viral tumors. Genes associated with monocyte activation had the highest expression levels in HBV, while high expression of genes involved in primary adaptive immune response and complement receptor activity characterized tumors without viral infection. Conclusions: Our comprehensive study underlines the high degree of complexity of immune profiles in the analyzed groups, which adds to the heterogeneous HCC genomic landscape. The biomarkers identified in each HCC group might serve as therapeutic targets.<\/jats:p>","DOI":"10.3390\/medicina58121803","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T05:50:52Z","timestamp":1670392252000},"page":"1803","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Comparative RNA-Sequencing Analysis Reveals High Complexity and Heterogeneity of Transcriptomic and Immune Profiles in Hepatocellular Carcinoma Tumors of Viral (HBV, HCV) and Non-Viral Etiology"],"prefix":"10.3390","volume":"58","author":[{"given":"Liliana","family":"Paslaru","sequence":"first","affiliation":[{"name":"Fundeni Clinical Institute, 022328 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6013-6645","authenticated-orcid":false,"given":"Gabriela","family":"Bindea","sequence":"additional","affiliation":[{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), Laboratory of Integrative Cancer Immunology, 75006 Paris, France"},{"name":"Centre de Recherche des Cordeliers, Sorbonne Universit\u00e9, Universit\u00e9 de Paris, 75006 Paris, France"},{"name":"Equipe Labellis\u00e9e Ligue Contre le Cancer, 75006 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca","family":"Nastase","sequence":"additional","affiliation":[{"name":"Fundeni Clinical Institute, 022328 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2617-4629","authenticated-orcid":false,"given":"Andrei","family":"Sorop","sequence":"additional","affiliation":[{"name":"Fundeni Clinical Institute, 022328 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2652-0931","authenticated-orcid":false,"given":"Cristian","family":"Zimbru","sequence":"additional","affiliation":[{"name":"Department of Automation and Applied Informatics, Politehnica University Timisoara, 300223 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0125-7815","authenticated-orcid":false,"given":"Vlad","family":"Herlea","sequence":"additional","affiliation":[{"name":"Fundeni Clinical Institute, 022328 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doina","family":"Hrehoret","sequence":"additional","affiliation":[{"name":"Fundeni Clinical Institute, 022328 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlad","family":"Brasoveanu","sequence":"additional","affiliation":[{"name":"Fundeni Clinical Institute, 022328 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu","family":"Zamfir","sequence":"additional","affiliation":[{"name":"Fundeni Clinical Institute, 022328 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5275-8938","authenticated-orcid":false,"given":"Simona","family":"Dima","sequence":"additional","affiliation":[{"name":"Fundeni Clinical Institute, 022328 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irinel","family":"Popescu","sequence":"additional","affiliation":[{"name":"Fundeni Clinical Institute, 022328 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,7]]},"reference":[{"key":"ref_1","unstructured":"(2021, May 01). Globocan. Available online: https:\/\/gco.iarc.fr\/today."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of Hepatocellular Carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","article-title":"Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"389","author":"Bruix","year":"2017","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S1470-2045(15)00050-9","article-title":"Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): A randomised, double-blind, multicentre, phase 3 trial","volume":"16","author":"Zhu","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma","volume":"379","author":"Forner","year":"2012","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","author":"Schulze","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.2741\/4057","article-title":"Obesity-related hepatocellular carcinoma: Roles of risk factors altered in obesity","volume":"17","author":"Shen","year":"2012","journal-title":"Front. Biosci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nrgastro.2010.100","article-title":"Hepatocellular carcinoma: A global view","volume":"7","author":"Yang","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/2213988501812010009","article-title":"Hepatocellular Carcinoma: Causes, Mechanism of Progression and Biomarkers","volume":"12","author":"Singh","year":"2018","journal-title":"Curr. Chem. Genom. Transl. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.canlet.2015.07.018","article-title":"Heterogeneity of liver cancer and personalized therapy","volume":"379","author":"Li","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cld.2015.01.001","article-title":"Global epidemiology of hepatocellular carcinoma: An emphasis on demographic and regional variability","volume":"19","author":"McGlynn","year":"2015","journal-title":"Clin. Liver Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s005350200149","article-title":"Understanding the hypercarcinogenic state in chronic hepatitis: A clue to the prevention of human hepatocellular carcinoma","volume":"37","author":"Hino","year":"2002","journal-title":"J. Gastroenterol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","article-title":"Hepatocellular carcinoma in cirrhosis: Incidence and risk factors","volume":"127","author":"Fattovich","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis","volume":"132","author":"Rudolph","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-0033-1345721","article-title":"Molecular mechanisms of HBV-associated hepatocarcinogenesis","volume":"33","author":"Guerrieri","year":"2013","journal-title":"Semin. Liver Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.21037\/jgo.2017.03.14","article-title":"Viral hepatitis and hepatocellular carcinoma: Etiology and management","volume":"8","author":"Zamor","year":"2017","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular Carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1200\/JCO.2005.03.196","article-title":"Hepatocellular carcinoma: The need for progress","volume":"23","author":"Thomas","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2147\/JHC.S61146","article-title":"Hepatocellular carcinoma: A review","volume":"3","author":"Balogh","year":"2016","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Barcena-Varela, M., and Lujambio, A. (2021). The Endless Sources of Hepatocellular Carcinoma Heterogeneity. Cancers, 13.","DOI":"10.3390\/cancers13112621"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nprot.2012.016","article-title":"Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks","volume":"7","author":"Trapnell","year":"2012","journal-title":"Nat. Protoc."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13059-021-02264-8","article-title":"GeneWalk identifies relevant gene functions for a biological context using network representation learning","volume":"22","author":"Ietswaart","year":"2021","journal-title":"Genome Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"D561","DOI":"10.1093\/nar\/gkq973","article-title":"The STRING database in 2011: Functional interaction networks of proteins, globally integrated and scored","volume":"39","author":"Szklarczyk","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: A software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: A Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinformatics"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/bioinformatics\/btt019","article-title":"CluePedia Cytoscape plugin: Pathway insights using integrated experimental and in silico data","volume":"29","author":"Bindea","year":"2013","journal-title":"Bioinformatics"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/nprot.2009.97","article-title":"Mapping identifiers for the integration of genomic datasets with the R\/Bioconductor package biomaRt","volume":"4","author":"Durinck","year":"2009","journal-title":"Nat. Protoc."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.gpb.2018.07.003","article-title":"HCCDB: A Database of Hepatocellular Carcinoma Expression Atlas","volume":"16","author":"Lian","year":"2018","journal-title":"Genom. Proteom. Bioinform."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"D816","DOI":"10.1093\/nar\/gkn673","article-title":"CTdatabase: A knowledge-base of high-throughput and curated data on cancer-testis antigens","volume":"37","author":"Almeida","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1124\/jpet.118.255018","article-title":"Deregulation of the Genes that Are Involved in Drug Absorption, Distribution, Metabolism, and Excretion in Hepatocellular Carcinoma","volume":"368","author":"Hu","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.mam.2012.12.007","article-title":"Solute carriers (SLCs) in cancer","volume":"34","author":"Bentz","year":"2013","journal-title":"Mol. Asp. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1111\/febs.15531","article-title":"A guide to plasma membrane solute carrier proteins","volume":"288","author":"Pizzagalli","year":"2021","journal-title":"FEBS J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.3892\/mmr.2016.5136","article-title":"Knockdown by shRNA identifies SLC44A5 as a potential therapeutic target in hepatocellular carcinoma","volume":"13","author":"Peng","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"618256","DOI":"10.3389\/fmed.2020.618256","article-title":"Physiological and Pathological Functions of SLC26A6","volume":"7","author":"Wang","year":"2020","journal-title":"Front. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1615\/CritRevEukaryotGeneExpr.2021039703","article-title":"Up-Regulation of SLC26A6 in Hepatocellular Carcinoma and Its Diagnostic and Prognostic Significance","volume":"31","author":"Zhu","year":"2021","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41416-021-01490-y","article-title":"SLC38A4 functions as a tumour suppressor in hepatocellular carcinoma through modulating Wnt\/beta-catenin\/MYC\/HMGCS2 axis","volume":"125","author":"Li","year":"2021","journal-title":"Br. J. Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"607613","DOI":"10.3389\/fphar.2020.607613","article-title":"Regulation Mechanisms of Expression and Function of Organic Cation Transporter 1","volume":"11","author":"Ciarimboli","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"115667","DOI":"10.18632\/oncotarget.23372","article-title":"Loss of organic cation transporter 3 (Oct3) leads to enhanced proliferation and hepatocarcinogenesis","volume":"8","author":"Vollmar","year":"2017","journal-title":"Oncotarget"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.18632\/genesandcancer.190","article-title":"Dissecting the expression landscape of cytochromes P450 in hepatocellular carcinoma: Towards novel molecular biomarkers","volume":"10","author":"Brodeur","year":"2019","journal-title":"Genes Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5175581","DOI":"10.1155\/2021\/5175581","article-title":"Downregulation of CYP39A1 Serves as a Novel Biomarker in Hepatocellular Carcinoma with Worse Clinical Outcome","volume":"2021","author":"Li","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2125.1998.00721.x","article-title":"Cytochrome P4502C9: An enzyme of major importance in human drug metabolism","volume":"45","author":"Miners","year":"1998","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/cam4.1299","article-title":"The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma","volume":"7","author":"Wang","year":"2018","journal-title":"Cancer Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"22058","DOI":"10.18632\/oncotarget.25178","article-title":"The down-regulation of the CYP2C19 gene is associated with aggressive tumor potential and the poorer recurrence-free survival of hepatocellular carcinoma","volume":"9","author":"Ashida","year":"2018","journal-title":"Oncotarget"},{"key":"ref_49","first-page":"445","article-title":"CYP3A4 Gene Is a Novel Biomarker for Predicting a Poor Prognosis in Hepatocellular Carcinoma","volume":"14","author":"Ashida","year":"2017","journal-title":"Cancer Genom. Proteom."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/jebm.12434","article-title":"ATP-binding cassette (ABC) transporters in cancer: A review of recent updates","volume":"14","author":"Wang","year":"2021","journal-title":"J. Evid. Based Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"118131","DOI":"10.1016\/j.lfs.2020.118131","article-title":"Systematic analysis of the ABC transporter family in hepatocellular carcinoma reveals the importance of ABCB6 in regulating ferroptosis","volume":"257","author":"Zhang","year":"2020","journal-title":"Life Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.2147\/IJGM.S333904","article-title":"Identification of ABCC5 Among ATP-Binding Cassette Transporter Family as a New Biomarker for Hepatocellular Carcinoma Based on Bioinformatics Analysis","volume":"14","author":"Qiu","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"10705","DOI":"10.1111\/jcmm.15691","article-title":"Genetic variation in ABCB5 associates with risk of hepatocellular carcinoma","volume":"24","author":"Leung","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.canlet.2019.05.010","article-title":"The ATP-binding cassette transporter ABCF1 is a hepatic oncofetal protein that promotes chemoresistance, EMT and cancer stemness in hepatocellular carcinoma","volume":"457","author":"Fung","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1533033820944274","DOI":"10.1177\/1533033820944274","article-title":"Cancer-Testis Gene Expression in Hepatocellular Carcinoma: Identification of Prognostic Markers and Potential Targets for Immunotherapy","volume":"19","author":"Zhang","year":"2020","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Noordam, L., Ge, Z., Ozturk, H., Doukas, M., Mancham, S., Boor, P.P.C., Campos Carrascosa, L., Zhou, G., van den Bosch, T.P.P., and Pan, Q. (2021). Expression of Cancer Testis Antigens in Tumor-Adjacent Normal Liver Is Associated with Post-Resection Recurrence of Hepatocellular Carcinoma. Cancers, 13.","DOI":"10.3390\/cancers13102499"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1016\/j.ygeno.2020.09.026","article-title":"A comprehensive analysis of the MAGE family as prognostic and diagnostic markers for hepatocellular carcinoma","volume":"112","author":"Li","year":"2020","journal-title":"Genomics"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2147\/OTT.S185858","article-title":"Upregulated expression of ACTL8 contributes to invasion and metastasis and indicates poor prognosis in colorectal cancer","volume":"12","author":"Han","year":"2019","journal-title":"Onco Targets Ther."},{"key":"ref_59","first-page":"877","article-title":"High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma","volume":"19","author":"Li","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/1759-7714.13247","article-title":"Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells","volume":"11","author":"Ma","year":"2020","journal-title":"Thorac. Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Liu, H., Wen, Q., Yan, S., Zeng, W., Zou, Y., Liu, Q., Zhang, G., Zou, J., and Zou, X. (2022). Tumor-Promoting ATAD2 and Its Preclinical Challenges. Biomolecules, 12.","DOI":"10.3390\/biom12081040"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"8657468","DOI":"10.1155\/2020\/8657468","article-title":"Integrated Bioinformatics Analysis of the Clinical Value and Biological Function of ATAD2 in Hepatocellular Carcinoma","volume":"2020","author":"Meng","year":"2020","journal-title":"BioMed Res. Int."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1126\/science.8451637","article-title":"Cells in stress: Transcriptional activation of heat shock genes","volume":"259","author":"Morimoto","year":"1993","journal-title":"Science"},{"key":"ref_64","unstructured":"Bhattacharya, S.R.S. (2018). The Science of Hormesis in Health and Longevity, Elsevier."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1006\/bbrc.2000.2295","article-title":"Cyclosporin A induces an atypical heat shock response","volume":"269","author":"Paslaru","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.tibs.2006.01.006","article-title":"Heat shock proteins in cancer: Chaperones of tumorigenesis","volume":"31","author":"Calderwood","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Syafruddin, S.E., Ling, S., Low, T.Y., and Mohtar, M.A. (2021). More Than Meets the Eye: Revisiting the Roles of Heat Shock Factor 4 in Health and Diseases. Biomolecules, 11.","DOI":"10.3390\/biom11040523"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/liv.14410","article-title":"HSP4 triggers epithelial-mesenchymal transition and promotes motility capacities of hepatocellular carcinoma cells via activating AKT","volume":"40","author":"Ma","year":"2020","journal-title":"Liver Int."},{"key":"ref_69","unstructured":"Semsey, S.A.S. (2013). Brenner\u2019s Encyclopedia of Genetics, Elsevier. [2nd ed.]."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fgene.2015.00211","article-title":"Why study moonlighting proteins?","volume":"6","author":"Jeffery","year":"2015","journal-title":"Front. Genet."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1365-2958.2007.06071.x","article-title":"Trigger enzymes: Bifunctional proteins active in metabolism and in controlling gene expression","volume":"67","author":"Commichau","year":"2008","journal-title":"Mol. Microbiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev-genet-030620-102906","article-title":"Moonlighting Proteins","volume":"54","author":"Singh","year":"2020","journal-title":"Annu. Rev. Genet."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1096\/fj00-0294rev","article-title":"Roles of the heat shock transcription factors in regulation of the heat shock response and beyond","volume":"15","author":"Pirkkala","year":"2001","journal-title":"FASEB J."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Prince, T.L., Lang, B.J., Guerrero-Gimenez, M.E., Fernandez-Munoz, J.M., Ackerman, A., and Calderwood, S.K. (2020). HSF1: Primary Factor in Molecular Chaperone Expression and a Major Contributor to Cancer Morbidity. Cells, 9.","DOI":"10.3390\/cells9041046"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00204-012-0918-z","article-title":"Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: An update","volume":"87","author":"Ciocca","year":"2013","journal-title":"Arch. Toxicol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/cncr.26482","article-title":"Heat shock factor 1 promotes invasion and metastasis of hepatocellular carcinoma in vitro and in vivo","volume":"118","author":"Fang","year":"2012","journal-title":"Cancer"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cell.2012.06.031","article-title":"HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers","volume":"150","author":"Mendillo","year":"2012","journal-title":"Cell"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13000-018-0755-3","article-title":"Increased expression of heat shock factor 1 (HSF1) is associated with poor survival in gastric cancer patients","volume":"13","author":"Dai","year":"2018","journal-title":"Diagn. Pathol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Tanguay, R.M., and Hightower, L.E. (2015). The Multicolored World of the Human HSPB Family. The Big Book on Small Heat Shock Proteins, Springer International Publishing.","DOI":"10.1007\/978-3-319-16077-1"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1242\/jcs.110.3.357","article-title":"Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27","volume":"110","author":"Guay","year":"1997","journal-title":"J. Cell Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3892\/ijo.2014.2399","article-title":"HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review)","volume":"45","author":"Wang","year":"2014","journal-title":"Int. J. Oncol."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Matsumoto, T., Urushido, M., Ide, H., Ishihara, M., Hamada-Ode, K., Shimamura, Y., Ogata, K., Inoue, K., Taniguchi, Y., and Taguchi, T. (2015). Small Heat Shock Protein Beta-1 (HSPB1) Is Upregulated and Regulates Autophagy and Apoptosis of Renal Tubular Cells in Acute Kidney Injury. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0126229"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"68156","DOI":"10.18632\/oncotarget.11905","article-title":"New HSP27 inhibitors efficiently suppress drug resistance development in cancer cells","volume":"7","author":"Heinrich","year":"2016","journal-title":"Oncotarget"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2174\/1568009614666140926122846","article-title":"Heat shock proteins as prognostic markers of cancer","volume":"14","author":"Kaigorodova","year":"2014","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s13577-020-00431-w","article-title":"Molecular characteristics associated with ferroptosis in hepatocellular carcinoma progression","volume":"34","author":"Fei","year":"2021","journal-title":"Hum. Cell"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.2147\/IJGM.S330608","article-title":"Heat Shock Protein Beta 1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma","volume":"14","author":"Long","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrm2918","article-title":"HSP90 at the hub of protein homeostasis: Emerging mechanistic insights","volume":"11","author":"Taipale","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.gene.2015.06.018","article-title":"Regulation and function of the human HSP90AA1 gene","volume":"570","author":"Zuehlke","year":"2015","journal-title":"Gene"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13277-015-4142-3","article-title":"Hsp90 regulates autophagy and plays a role in cancer therapy","volume":"37","author":"Wang","year":"2016","journal-title":"Tumor Biol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"9110","DOI":"10.1002\/jcp.29776","article-title":"The role of HSP90 molecular chaperones in hepatocellular carcinoma","volume":"235","author":"Alizadeh","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"ref_91","first-page":"2477","article-title":"Biological characteristics of heat shock protein 90 in human liver cancer cells","volume":"11","author":"Qin","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.3892\/mmr.2015.3725","article-title":"Role of the novel HSP90 inhibitor AUY922 in hepatocellular carcinoma: Potential for therapy","volume":"12","author":"Cheng","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41580-019-0133-3","article-title":"The Hsp70 chaperone network","volume":"20","author":"Rosenzweig","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.4161\/cc.5.22.3448","article-title":"Heat shock proteins 27 and 70: Anti-apoptotic proteins with tumorigenic properties","volume":"5","author":"Garrido","year":"2006","journal-title":"Cell Cycle"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Albakova, Z., Armeev, G.A., Kanevskiy, L.M., Kovalenko, E.I., and Sapozhnikov, A.M. (2020). HSP70 Multi-Functionality in Cancer. Cells, 9.","DOI":"10.3390\/cells9030587"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s12935-021-01987-9","article-title":"The expression profiles and prognostic values of HSP70s in hepatocellular carcinoma","volume":"21","author":"Wang","year":"2021","journal-title":"Cancer Cell Int."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.canlet.2011.11.020","article-title":"Extracellular HSPA1A promotes the growth of hepatocarcinoma by augmenting tumor cell proliferation and apoptosis-resistance","volume":"317","author":"Wu","year":"2012","journal-title":"Cancer Lett."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Jiang, H., Liang, Z., Qin, S., and Liu, K. (2020). Prognostic Value of Members of the HSP70 Family in Hepatocellular Carcinoma, preprint.","DOI":"10.21203\/rs.3.rs-30115\/v1"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3346\/jkms.2005.20.5.829","article-title":"Expressions of HSP70 and HSP27 in hepatocellular carcinoma","volume":"20","author":"Joo","year":"2005","journal-title":"J. Korean Med. Sci."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.3892\/ol.2017.6531","article-title":"Heat shock protein 70 downregulation inhibits proliferation, migration and tumorigenicity in hepatocellular carcinoma cells","volume":"14","author":"Xiong","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_101","first-page":"289","article-title":"The ER function BiP is a master regulator of ER function","volume":"71","author":"Hendershot","year":"2004","journal-title":"Mt. Sinai J. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ymeth.2004.10.010","article-title":"The ER chaperone and signaling regulator GRP78\/BiP as a monitor of endoplasmic reticulum stress","volume":"35","author":"Lee","year":"2005","journal-title":"Methods"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"20915","DOI":"10.1074\/jbc.M212328200","article-title":"Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: Role of ATP binding site in suppression of caspase-7 activation","volume":"278","author":"Reddy","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4161\/auto.3653","article-title":"Endoplasmic reticulum stress: A new pathway to induce autophagy","volume":"3","author":"Yorimitsu","year":"2007","journal-title":"Autophagy"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/cdd.2008.81","article-title":"The unfolded protein response regulator GRP78\/BiP is required for endoplasmic reticulum integrity and stress-induced autophagy in mammalian cells","volume":"15","author":"Li","year":"2008","journal-title":"Cell Death Differ."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Su, R., Li, Z., Li, H., Song, H., Bao, C., Wei, J., and Cheng, L. (2010). Grp78 promotes the invasion of hepatocellular carcinoma. BMC Cancer, 10.","DOI":"10.1186\/1471-2407-10-20"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"112005","DOI":"10.1016\/j.biopha.2021.112005","article-title":"Endoplasmic reticulum stress: Multiple regulatory roles in hepatocellular carcinoma","volume":"142","author":"Wu","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/abio.2001.5570","article-title":"Housekeeping gene variability in normal and carcinomatous colorectal and liver tissues: Applications in pharmacogenomic gene expression studies","volume":"303","author":"Blanquicett","year":"2002","journal-title":"Anal. Biochem."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.1080\/21655979.2021.1973220","article-title":"A pan-cancer analysis of the prognostic and immunological role of beta-actin (ACTB) in human cancers","volume":"12","author":"Gu","year":"2021","journal-title":"Bioengineered"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41419-019-1968-4","article-title":"Targeting a moonlighting function of aldolase induces apoptosis in cancer cells","volume":"10","author":"Gizak","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/hep.31846","article-title":"Loss-of-Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia","volume":"74","author":"Niu","year":"2021","journal-title":"Hepatology"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"88232","DOI":"10.18632\/oncotarget.21088","article-title":"Cortactin in cancer cell migration and invasion","volume":"8","author":"Yin","year":"2017","journal-title":"Oncotarget"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jhep.2004.06.018","article-title":"Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma","volume":"41","author":"Chuma","year":"2004","journal-title":"J. Hepatol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbrc.2021.01.017","article-title":"Sleeping Beauty insertional mutagenesis screen identifies the pro-metastatic roles of CNPY2 and ACTN2 in hepatocellular carcinoma tumor progression","volume":"541","author":"Lo","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Roy, N., Lodh, R., Sarma, A., Bhattacharyya, D.K., and Barah, P. (2021). Integrative analysis identified common and unique molecular signatures in hepatobiliary cancers. bioRxiv.","DOI":"10.1101\/2021.10.06.463304"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"671","DOI":"10.20892\/j.issn.2095-3941.2019.0228","article-title":"Crucial role of Anxa2 in cancer progression: Highlights on its novel regulatory mechanism","volume":"16","author":"Wang","year":"2019","journal-title":"Cancer Biol. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.7150\/jca.55173","article-title":"Advances in cancer treatment: A new therapeutic target, Annexin A2","volume":"12","author":"Li","year":"2021","journal-title":"J. Cancer"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s13277-015-3524-x","article-title":"Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma","volume":"37","author":"Fawzy","year":"2016","journal-title":"Tumor Biol."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Guo, M., Lu, S., Huang, H., Wang, Y., Yang, M.Q., Yang, Y., Fan, Z., Jiang, B., and Deng, Y. (2018). Increased AURKA promotes cell proliferation and predicts poor prognosis in bladder cancer. BMC Syst. Biol., 12.","DOI":"10.1186\/s12918-018-0634-2"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1053\/j.gastro.2018.10.030","article-title":"Inhibition of AURKA Reduces Proliferation and Survival of Gastrointestinal Cancer Cells With Activated KRAS by Preventing Activation of RPS6KB1","volume":"156","author":"Chen","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"170","DOI":"10.7150\/ijms.22513","article-title":"Variations in the AURKA Gene: Biomarkers for the Development and Progression of Hepatocellular Carcinoma","volume":"15","author":"Wang","year":"2018","journal-title":"Int. J. Med. Sci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.bbrc.2017.03.075","article-title":"AURKA promotes cancer metastasis by regulating epithelial-mesenchymal transition and cancer stem cell properties in hepatocellular carcinoma","volume":"486","author":"Chen","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12943-020-01305-3","article-title":"Targeting AURKA in Cancer: Molecular mechanisms and opportunities for Cancer therapy","volume":"20","author":"Du","year":"2021","journal-title":"Mol. Cancer"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"11769343211057589","DOI":"10.1177\/11769343211057589","article-title":"AURKB as a Promising Prognostic Biomarker in Hepatocellular Carcinoma","volume":"17","author":"Xiao","year":"2021","journal-title":"Evol. Bioinform."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.humpath.2017.10.032","article-title":"BRCA1 and BRCA2 expression patterns and prognostic significance in digestive system cancers","volume":"71","author":"Wang","year":"2018","journal-title":"Hum. Pathol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1089\/dna.2020.5644","article-title":"BRCA1 Is a Novel Prognostic Indicator and Associates with Immune Cell Infiltration in Hepatocellular Carcinoma","volume":"39","author":"Mei","year":"2020","journal-title":"DNA Cell Biol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"E73","DOI":"10.1038\/11041","article-title":"Four-dimensional control of the cell cycle","volume":"1","author":"Pines","year":"1999","journal-title":"Nat. Cell Biol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.ceb.2010.07.015","article-title":"Cyclin-dependent kinase-dependent initiation of chromosomal DNA replication","volume":"22","author":"Araki","year":"2010","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"300060520910019","DOI":"10.1177\/0300060520910019","article-title":"Identification of potential hub genes associated with the pathogenesis and prognosis of hepatocellular carcinoma via integrated bioinformatics analysis","volume":"48","author":"Meng","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.7150\/thno.25487","article-title":"Blocking CDK1\/PDK1\/beta-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma","volume":"8","author":"Wu","year":"2018","journal-title":"Theranostics"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Liu, X., Wu, H., and Liu, Z. (2022). An Integrative Human Pan-Cancer Analysis of Cyclin-Dependent Kinase 1 (CDK1). Cancers, 14.","DOI":"10.3390\/cancers14112658"},{"key":"ref_132","first-page":"3518378","article-title":"Identification of Key Genes and Prognostic Value Analysis in Hepatocellular Carcinoma by Integrated Bioinformatics Analysis","volume":"2019","author":"Wang","year":"2019","journal-title":"Int. J. Genom."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e925289","DOI":"10.12659\/MSM.925289","article-title":"CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma","volume":"26","author":"Zou","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1038\/sj.onc.1209377","article-title":"Cytochrome P450 pharmacogenetics and cancer","volume":"25","year":"2006","journal-title":"Oncogene"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.2147\/CMAR.S159425","article-title":"The prognostic value of differentially expressed CYP3A subfamily members for hepatocellular carcinoma","volume":"10","author":"Yu","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.7150\/thno.49368","article-title":"CYP1A2 suppresses hepatocellular carcinoma through antagonizing HGF\/MET signaling","volume":"11","author":"Yu","year":"2021","journal-title":"Theranostics"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/hep.24536","article-title":"Oxidative stress pathways in noncancerous human liver tissue to predict hepatocellular carcinoma recurrence: A prospective, multicenter study","volume":"54","author":"Tanaka","year":"2011","journal-title":"Hepatology"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijrobp.2003.11.041","article-title":"Review of epidermal growth factor receptor biology","volume":"59","author":"Herbst","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1002\/jcb.26625","article-title":"EGF is highly expressed in hepatocellular carcinoma (HCC) and promotes motility of HCC cells via fibronectin","volume":"119","author":"Liu","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"104726","DOI":"10.1016\/j.phrs.2020.104726","article-title":"Telomerase: Key regulator of inflammation and cancer","volume":"155","author":"Wu","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/jmv.21644","article-title":"Hepatitis C virus core protein enhances Telomerase activity in Huh7 cells","volume":"82","author":"Zhu","year":"2010","journal-title":"J. Med. Virol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/viro.2000.0295","article-title":"Hepatitis C virus core protein promotes immortalization of primary human hepatocytes","volume":"271","author":"Ray","year":"2000","journal-title":"Virology"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1042\/bj3030681","article-title":"Structure and function of type II DNA topoisomerases","volume":"303","author":"Watt","year":"1994","journal-title":"Biochem. J."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"381602","DOI":"10.1155\/2015\/381602","article-title":"TOP2A amplification and overexpression in hepatocellular carcinoma tissues","volume":"2015","author":"Panvichian","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12935-021-02439-0","article-title":"Study on the expression of TOP2A in hepatocellular carcinoma and its relationship with patient prognosis","volume":"22","author":"Meng","year":"2022","journal-title":"Cancer Cell Int."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1053\/j.gastro.2017.06.007","article-title":"Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features","volume":"153","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.21037\/tcr-20-1751","article-title":"Systemic characterization of the SLC family genes reveals SLC26A6 as a novel oncogene in hepatocellular carcinoma","volume":"10","author":"Cao","year":"2021","journal-title":"Transl. Cancer Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1111\/j.1349-7006.2009.01303.x","article-title":"Cancer\/testis (CT) antigens: Potential targets for immunotherapy","volume":"100","author":"Caballero","year":"2009","journal-title":"Cancer Sci."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"188558","DOI":"10.1016\/j.bbcan.2021.188558","article-title":"Oncogenic cancer\/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy","volume":"1876","author":"Yang","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"16121","DOI":"10.1074\/jbc.REV120.008029","article-title":"Emerging roles of the MAGE protein family in stress response pathways","volume":"295","author":"Chen","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1477-2574.2010.00207.x","article-title":"Evidence of aberrant lipid metabolism in hepatitis C and hepatocellular carcinoma","volume":"12","author":"Wu","year":"2010","journal-title":"HPB"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"2019896","DOI":"10.1080\/2162402X.2021.2019896","article-title":"Immune sunrise: From the immunome to the cancer immune landscape","volume":"11","author":"Bindea","year":"2022","journal-title":"Oncoimmunology"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Mlecnik, B., Torigoe, T., Bindea, G., Popivanova, B., Xu, M., Fujita, T., Hazama, S., Suzuki, N., Nagano, H., and Okuno, K. (2022). Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study. Cancers, 14.","DOI":"10.3390\/cancers14184346"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1158\/2159-8290.CD-15-0944","article-title":"Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy","volume":"6","author":"Blake","year":"2016","journal-title":"Cancer Discov."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/hep.30347","article-title":"Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma","volume":"70","author":"Sun","year":"2019","journal-title":"Hepatology"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13000-021-01118-y","article-title":"Identification of immune-infiltrating cell-related biomarkers in hepatocellular carcinoma based on gene co-expression network analysis","volume":"16","author":"Hou","year":"2021","journal-title":"Diagn. Pathol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/12\/1803\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:35:44Z","timestamp":1760146544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/12\/1803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,7]]},"references-count":157,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["medicina58121803"],"URL":"https:\/\/doi.org\/10.3390\/medicina58121803","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,7]]}}}